XIII SBBN Congress and 20th IUPAB Congress, Foz do Iguaçu, 26-30/10/2020

Since 2017, the Brazilian Society on Nuclear Biosciences (SBBN) is affiliated to the International Union for Pure and Applied Biophysics (IUPAB).

The XIII SBBN Congress will be held in parallel with the 20th International Congress of IUPAB, the 45th Annual Brazilian Biophysical Society (SBBf) Meeting, and 49th Annual Brazilian Biochemistry and Molecular Biology Society (SBBq) Meeting. All participants may attend these four events paying only one inscription.

The Annual Meetings of SBBf and SBBq are two of the most traditional events within the Brazilian scientific community. They have been the forum of choice for presentations and discussions regarding the state of the art in biologically relevant phenomena, as well as their social benefits. Science policy, integration with other segments of the economy and outreach activities have also been among the main focuses of these events.

SBBN Keynote Lectures (60 min)
• Biomolecules and drug development (Amir Jalilian, Researcher of the Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria) – to be confirmed
• Alpha radionuclides therapy and bone marrow dosimetry (George Sgouros, Director of the Johns Hopkins Medicine Department of Radiology and Radiological Science, Baltimore, USA) – to be confirmed.
• Charged particle in Radiation Oncology (Marco Durante (Director of the Biophysics Department of GSI Helmholtz Centre for Heavy Ion Research, Darmstadt, Germany)
• Nuclear accidents and decision making in the perspective of environmental radiological releases (Matthew Healy, Cranfield University, UK)

SBBN Symposia (120 min)

Biomaterials and molecular imaging techniques
• Theranostic radiopharmaceuticals (Suzane Lapi, Department of Radiology, Cyclotron Facility Director, University of Alabama at Birmingham, Alabama, USA)
• Total-Body Radiotracer Pharmacokinetics and Molecular Imaging (Simon R. Cherry, Department of Biomedical Engineering and Department of Radiology, University of California, Davis, USA)
• Molecular imaging for research in Oncology (Carlos Buchpiguel, Professor and Director of the Nuclear Medicine Center, Sao Paulo University Medical School, Brazil)

Molecular Imaging in Neurosciences
• New trends in PET radiopharmaceuticals for neurodegenerative diseases (Eduardo Savio, Head of the Radiopharmacy, Research and Development Department, Uruguayan Centre for Molecular Imaging, Montevideo, Uruguay)
• Pericytes and the intersection between tissue regeneration and pathology (Alexander Birbrair, Professor at the Pathology Department of the Biological Sciences Institute of the Federal University of Minas Gerais, Belo Horizonte, Brazil)
• PET/CT/MRI fusion images showing cranial and peripheral nerve involvement in neurolymphomatosis (Lauro Wichert-Ana, Professor and Coordinator of the Nuclear Medicine Division, Ribeirão Preto Medical School, University of São Paulo, Brazil)

Radiobiology and Radiotherapy
• Radiation interaction and response from cells and tissues: radiation risk models versus individualized medicine (Dunstana Melo, Melohill Tech., Washington, USA)
• Dose fractionation in Radiotherapy patients (Helena Segreto, EPM- UNIFESP, Brazilian Society on Radiotherapy-SBRT, São Paulo, Brazil)
• Development of three-dimensional cellular culture system for testing of biological effects of radiations in tumoral and non-tumoral models (Daniel Perez, Nuclear and Engineering Research Institute- IPEN, São Paulo, SP)

Challenges for clinical studies in Brazil and the regulatory framework
• Clinical studies design, patients sampling and ethics committees: Brazilian experiences (Juliano Cerci, Brazilian Society on Nuclear Medicine-SBMN, Curitiba, Brazil)
• Education and individual capabilities in the multidisciplinary teams for developing clinical studies (Ana Maria Marques da Silva, PUC-RS, Porto Alegre, Brazil)
• The reference hospitals, the equipment state-of-the art and the regional inequities (Jorge Wagner E. da Silva, National Cancer Institute, Health Ministry, Rio de Janeiro, Brazil)

IUPAB-SBBN Symposium: Nanobiotechnology. Chair: Valtencir Zucolotto (IFSC-USP, Brazil)

IUPAB-SBBN Symposium: Biophotonics. Chair: to be confirmed.

IUPAB Invited speakers (confirmed)

Richard Henderson, MRC Labs, Cambridge, UK – molecular biologist and biophysicist and pioneer in the field of electron microscopy of biological molecules. He shared the Nobel Prize in Chemistry in 2017 with Jacques Dubochet and Joachim Frank.
Michael Levitt, Stanford University – biophysicist and a professor of structural Biology. He received the 2013 Nobel Prize in Chemistry, together with Martin Karplus and Arieh Warshel, for “the development of multiscale models for complex chemical systems
Chris Dobson, University of Cambridge – chemist, who is the John Humphrey Plummer Professor of Chemical and Structural Biology. In 2014 he received both the Heineken Prize for Biochemistry and Biophysics and the Feltrinelli International Prize for Medicine.
Angela Gronenborn, Ph.D. in physical chemistry (University of Cologne, Germany). She did postdoctoral work with protein NMR pioneer James Feeney at the National Institute for Medical Research in London. Since 2004, she is the Department of Structural Biology Chief in University of Pittsburgh.
Ohara Augusto is Full Professor of Biochemistry at Universidade de São Paulo, Brazil. Her research interests are focused on kinetics and mechanisms of redox enzymes, oxidant and antioxidant mechanisms, infection and inflammation. She is member of the Brazilian Academy of Science, of the Third World Academy of Sciences and is Fellow of the Society for Redox Biology and Medicine.
Ramon Latorre is Full professor of Neuroscience Institute from University of Valparaiso, Chile and Director of Interdisciplinary Center of Neuroscience of Valparaiso. His research interests are focused on understanding how the protein domains involved in sensing stimuli (sensors) and opening the pore (gates) communicate. He is member of Latin America Science Academy Council and Foreign Member of National Academy of Sciences, USA.

SBBN invited speakers:

Amir Jalilian, PhD in Pharmacy, Tehran University of Medical Sciences, pos-doc in Molecular Biology at the School of Medicine, Yale University (EUA) and pos-doc at the Faculty of Pharmacy and Medical Sciences, University of Alberta, Canadá. Researcher at the Nuclear Sciences and Applications Department, International Atomic Energy Agency, Vienna, Austria.

Dunstana Melo, Ph.D. in Biophysics from the Federal University of Rio de Janeiro, Brazil. Melohill Technology LLC President. She has experience in radiation protection, dosimetry, biokinetics, and biological effects of internally deposited radionuclides and methods for removing radionuclides from the body (decorporation). She has served on the National Council on Radiation Protection and Measurements (NCRP) and on the International Commission on Radiological Protection (ICRP) from 2006 to present.

Eduardo Savio, PhD in Chemistry. Director in Research and Development, Biomedical and Chemical Deparments, Uruguayan Centre for Molecular Imaging (CUDIM), Montevideo, Uruguay.

Marco Durante, PhD in Radiation Biophysics at the University of Naples Federico II, Italy.
Director of the Biophysics Department, GSI Helmholtz Center, Darmstadt, Germany and International Association for Radiation Research (IARR) President. Prizes: Galileo Galilei prize from the European Federation of Organizations for Medical Physics (2005); 60th Timofeeff-Ressovsky medal by the Russian Academy of Sciences (2010); 8th Warren K. Sinclair Award of the US National Academy of Sciences (2011).

Matthew J F Healy, senior research, Cranfield University, UK. International consultancy activities have included methods and technologies, decision support following the Fukushima accident, performing biological, chemistry, radiological and nuclear vulnerability assessments, independent requirements capture and assessing the cost of recovering from terrorism.

Simon Cherry, PhD in Biomedical Engineering, Professor at the University of California, Davis, USA. The Cherry Lab focuses on molecular imaging using positron emission tomography (PET) scanning. The team is currently studying pathologic processes that involve multiple organs systems or the entire body, the EXPLORER project, a collaboration with several colleagues to develop the world’s first total-body PET scanner. In 2018, he received the Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science.

Susanne Lapi, PhD in Chemistry. She is the Cyclotron Facility and Radiochemistry Laboratory and the Division of Advanced Medical Imaging Research Director and Associate Professor, Department of Radiology and Chemistry, at the University of Alabama at Birmingham. She is member of the International Society of Radiopharmaceutical Sciences (ISRS) Council.